Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
United European Gastroenterology Journal|November 3, 2018
Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis CMasaru Enomoto, Yoshihiro Ikura, Akihiro Tamori, et al.Journal of Gastroenterology and Hepatology|January 22, 2017
Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapyRitsuzo Kozuka, Hoang Hai, Yuga Teranishi, et al.Scientific Reports|January 9, 2020
Development of a novel anti-hepatitis B virus agent via Sp1Michiyo Hayakawa, Hideaki Umeyama, Mitsuo Iwadate, et al.Scientific Reports|April 22, 2020
Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1Michiyo Hayakawa, Hideaki Umeyama, Mitsuo Iwadate, et al.Journal of Viral Hepatitis|December 30, 2022
Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohortRitsuzo Kozuka, Akihiro Tamori, Masaru Enomoto, et al.Journal of Gastroenterology and Hepatology|August 31, 2018
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatmentRitsuzo Kozuka, Masaru Enomoto, Misako Sato-Matsubara, et al.Annals of Hepatology|August 16, 2017
Outcomes for Cirrhotic Patients with Hepatitis C Virus 1b Treated with Asunaprevir and Daclatasvir CombinationAkihiro Tamori, Hoang Hai, Sawako Uchida-Kobayashi, et al.International Journal of Molecular Sciences|May 4, 2017
Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy FailedKanako Yoshida, Hoang Hai, Akihiro Tamori, et al.Annals of Hepatology|May 24, 2020
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patientsKanako Kikukawa, Sawako Uchida-Kobayashi, Akihiro Tamori, et al.Journal of Viral Hepatitis|October 25, 2021
Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatmentHiroko Ikenaga, Sawako Uchida-Kobayashi, Akihiro Tamori, et al.Pageof 6